Latest Breaking News On - Affairs at longeveron - Page 1 : vimarsana.com

MIAMI, Nov. 05, 2021 (GLOBE NEWSWIRE) Longeveron Inc. (NASDAQ: LGVN) ("Longeveron" or "Company"), a clinical stage biotechnology company developing cellular therapies for chronic aging-related and life-threatening conditions, today announced

United statesKevinn ramdasAffairs at longeveronLongeveron inc sourceLongeveron or companyLongeveron incMedical affairsAging frailtyMetabolic syndromeAcute respiratory distress syndromeBrendan payne stern investor relations tel